fbpx
November 15, 2022

Novel Nasal Spray for Acute Migraine Disappoints in Phase 3 Trial Novel Nasal Spray for Acute Migraine Disappoints in Phase 3 Trial

An investigational dihydroergotamine nasal spray for the acute treatment of migraine failed to meet its co-primary endpoints in a late-stage study, according to topline results announced […]
November 15, 2022

Could There Be a Better Treatment for MS Relapses? Could There Be a Better Treatment for MS Relapses?

What should you do if a patient with multiple sclerosis suffers an acute relapse, but the standard methylprednisolone treatment does not result in any improvement? As […]
November 14, 2022

Novel Alzheimer’s Treatment Disappoints in Twin Phase 3 Trials Novel Alzheimer’s Treatment Disappoints in Twin Phase 3 Trials

The investigational anti-amyloid monoclonal antibody gantenerumab (Genentech/Roche) showed no clear benefit for patients with early Alzheimer’s disease (AD) in the phase 3 GRADUATE I and II […]
November 11, 2022

Why Do Women Get Alzheimer’s More Than Men? Study Offers Clue Why Do Women Get Alzheimer’s More Than Men? Study Offers Clue

Of the more than 6 million Alzheimer’s patients in the U.S. age 65 or older, nearly two-thirds are women. A new study may help explain the gender gap — […]
November 11, 2022

Nutrition for Cognition a Missed Opportunity in US Seniors? Nutrition for Cognition a Missed Opportunity in US Seniors?

Among older adults who use the US Supplemental Nutrition Assistance Program (SNAP), rates of memory decline appear to be slower than among those who don’t use […]
November 9, 2022

TNF Inhibitors Linked to Increased Multiple Sclerosis Risk TNF Inhibitors Linked to Increased Multiple Sclerosis Risk

Anti-tumor necrosis factor alpha (TNF-alpha) inhibitors are associated with an increased risk for multiple sclerosis (MS), especially among patients with rheumatic disease (RD), new research shows. […]
November 8, 2022

Stem Cell Therapy Strikes Out in Progressive MS Stem Cell Therapy Strikes Out in Progressive MS

In two retrospective studies that drew from the international MSBase registry, autologous hematopoietic stem cell therapy (AHSCT) did not outperform a disease-modifying therapy (DMT) in patients […]
November 8, 2022

Early Weight Loss Tied to Faster Cognitive Decline in Parkinson’s Early Weight Loss Tied to Faster Cognitive Decline in Parkinson’s

Early weight loss after a diagnosis of Parkinson’s disease (PD) may be a harbinger of more rapid deterioration in cognitive function, new research suggests. Results showed […]
November 8, 2022

More Evidence for Epstein-Barr Virus’ Role in MS More Evidence for Epstein-Barr Virus’ Role in MS

Epstein-Barr Virus (EBV) is a suspect in the development of multiple sclerosis (MS), and recent research developments have strengthened that connection. In 2022, two studies received […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0